Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CATM
1926
CALL
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $5.36M | ﹤0.01% |
+120,000
| New | +$4.56M |
|
1927
Bunge Global
BG
$20.8B
| $5.36M | ﹤0.01% |
93,057
+6,470
| +7% | +$358K |
|
1928
UMB Financial
UMBF
$11.1B
| $5.34M | ﹤0.01% |
77,858
+37,765
| +94% | +$2.51M |
|
|
ADVM
1929
DELISTED
Adverum Biotechnologies
ADVM
| $5.34M | ﹤0.01% |
46,324
+41,814
| +927% | +$3.69M |
|
1930
PUT
ON Semiconductor
ON
$31.6B
| $5.32M | ﹤0.01% |
218,000
+143,800
| +194% | +$3.04M |
|
1931
LXP Industrial Trust
LXP
$3.57B
| $5.31M | ﹤0.01% |
100,011
+18,548
| +23% | +$993K |
|
|
CCH.U
1932
DELISTED
Collier Creek Holdings Units, each consisting of one Class A ordinary share, $0.0001 par value, and
CCH.U
| $5.31M | ﹤0.01% |
500,000
| – | – |
|
|
PPL
1933
PUT
PPL Corp
PPL
$26.7B
| $5.3M | ﹤0.01% |
147,700
+80,400
| +119% | +$2.69M |
|
1934
CALL
BP
BP
$107B
| $5.3M | ﹤0.01% |
140,400
-216,300
| -61% | -$8.21M |
|
1935
CALL
GSK
GSK
$106B
| $5.3M | ﹤0.01% |
90,160
-12,400
| -12% | -$690K |
|
1936
Service Corp International
SCI
$11.6B
| $5.29M | ﹤0.01% |
114,834
+74,065
| +182% | +$3.34M |
|
|
CEO
1937
PUT
DELISTED
CNOOC Limited
CEO
| $5.28M | ﹤0.01% |
31,700
-6,500
| -17% | -$995K |
|
1938
Antero Resources
AR
$10.7B
| $5.26M | ﹤0.01% |
1,845,783
-149,315
| -7% | -$381K |
|
1939
Watts Water Technologies
WTS
$13.1B
| $5.26M | ﹤0.01% |
52,731
+3,129
| +6% | +$297K |
|
1940
CALL
Genuine Parts
GPC
$18.7B
| $5.26M | ﹤0.01% |
49,500
-1,700
| -3% | -$175K |
|
1941
PUT
Masco
MAS
$15.3B
| $5.25M | ﹤0.01% |
109,400
+31,100
| +40% | +$1.41M |
|
|
NEWR
1942
PUT
DELISTED
New Relic, Inc.
NEWR
| $5.25M | ﹤0.01% |
+79,900
| New | +$5.19M |
|
1943
AMN Healthcare
AMN
$1.4B
| $5.24M | ﹤0.01% |
84,129
+21,653
| +35% | +$1.28M |
|
1944
PUT
VF Corp
VFC
$5.89B
| $5.24M | ﹤0.01% |
52,600
-1,000
| -2% | -$89.6K |
|
1945
Curtiss-Wright
CW
$25.5B
| $5.24M | ﹤0.01% |
37,187
-85,658
| -70% | -$11.6M |
|
1946
PUT
Pan American Silver
PAAS
$21.6B
| $5.24M | ﹤0.01% |
221,100
+48,200
| +28% | +$893K |
|
1947
California Water Service
CWT
$3.12B
| $5.24M | ﹤0.01% |
101,558
+34,952
| +52% | +$1.82M |
|
1948
Gray Television
GTN
$552M
| $5.23M | ﹤0.01% |
244,014
+78,588
| +48% | +$1.46M |
|
1949
CALL
Blackrock
BLK
$176B
| $5.23M | ﹤0.01% |
10,400
+900
| +9% | +$427K |
|
|
HMSY
1950
DELISTED
HMS Holdings Corp.
HMSY
| $5.21M | ﹤0.01% |
176,155
+19,905
| +13% | +$611K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.